SCHEMBL2779188

SCHEMBL2779188

C1=CCC2C[C]2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5338380 0.81
SCHEMBL15653642 0.72
SCHEMBL4526733 0.69
SCHEMBL3773813 0.60
SCHEMBL1116310 0.58
SCHEMBL1524919 0.56
SCHEMBL8510366 0.53 SLC18A3 (0.48)
SCHEMBL1524774 0.52
SCHEMBL71691 0.49
SCHEMBL2137530 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020239076-A1 PYRIDAZINONE DERIVATIVES AS THYROXINE RECEPTOR-Β AGONISTS AND APPLICATION THEREOF 南京明德新药研发有限公司 2020-12-03 WO claimed
EP-1477485-A1 Aminophenol derivatives Bayer CropScience AG (DE) 2004-11-17 EP claimed
EP-0934302-B1 AMINOPHENOL DERIVATES BAYER CROPSCIENCE AG (DE) 2004-08-25 EP claimed
US-6194443-B1 Aminophenol derivatives with fungicidal property BAYER AKTIENGESELLSCHAFT (DE) 2001-02-27 US claimed
EP-0010941-A1 5-Fluorouracil derivatives, preparation thereof and their pharmaceutical compositions FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-05-14 EP claimed
US-12030869-B2 5-membered heteroaryl carboxamide compounds for treatment of HBV ASSEMBLY BIOSCIENCES, INC. (US) 2024-07-09 US disclosed
US-20240150324-A1 5-Membered Heteroaryl Carboxamide Compounds for Treatment of HBV ASSEMBLY BIOSCIENCES, INC. 2024-05-09 US disclosed
WO-2024067465-A1 KIF18A INHIBITOR 山东轩竹医药科技有限公司 2024-04-04 WO disclosed
US-20240101566-A1 TRICYCLIC UBIQUITIN SPECIFIC PROTEASE 1 INHIBITOR AND USE THEREOF Xuanzhu Biopharmaceutical Co., Ltd. (CN) 2024-03-28 US disclosed
EP-4335852-A1 TRICYCLIC UBIQUITIN SPECIFIC PROTEASE 1 INHIBITOR AND USE THEREOF Shandong Xuanzhu Pharma Co., Ltd. (CN) 2024-03-13 EP disclosed
WO-2024032661-A1 KIF18A INHIBITOR AND USE THEREOF 山东轩竹医药科技有限公司 2024-02-15 WO disclosed
US-20230295096-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES INC (US) 2023-09-21 US disclosed
EP-0808102-A1 FUNGICIDE BASF AKTIENGESELLSCHAFT (DE) 1997-11-26 EP disclosed
WO-1997035838-A1 FUNGICIDALLY ACTIVE CARBOXYLIC ACID AMIDES BASF AKTIENGESELLSCHAFT (DE) 1997-10-02 WO disclosed
EP-0653418-B1 P-hydroxy-aniline derivatives, process for their preparation and their use as fungicides or pesticides BASF AG (DE) 1997-03-05 EP disclosed
WO-1996024249-A1 FUNGICIDE BASF AKTIENGESELLSCHAFT (DE) 1996-08-15 WO disclosed
US-5534653-A FUNGICIDES, PESTICIDES BASF AKTIENGESELLSCHAFT (DE) 1996-07-09 US disclosed
EP-0653418-A1 P-hydroxy-aniline derivatives, process for their preparation and their use as fungicides or pesticides BASF Aktiengesellschaft (DE) 1995-05-17 EP disclosed
US-4349552-A TREATMENT OF CANCER FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1982-09-14 US disclosed
EP-0010941-A1 5-Fluorouracil derivatives, preparation thereof and their pharmaceutical compositions FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-05-14 EP disclosed